To order printed copies, please, click here. All publications are free of charge.
To read a 2-page summary of these publications click here.
To visit these publications, please, choose a title:
The report provides a review of the scientific evidence that certain chemicals may be implicated in breast cancer, and focuses on the role of hormone disrupting chemicals. Particular reference is made to early life and multiple chemical exposures. Written by Professor Andreas Kortenkamp, Head of the Centre for Toxicology, School of Pharmacy, University of London, UK, the report has been peer reviewed by Professor Jan Ake Gustafsson (whose team discovered the oestrogen receptor-beta), Dr Julia Brody from the Silent Spring Institute, USA, and Prof Alastair M Thompson, Professor of Surgical Oncology at the University of Dundee.
The fully referenced report identifies important areas for further discussion not only within the breast cancer and wider medical community but also within that of chemicals regulation.
The report is available for downloading as a PDF document in:
This briefing summarizes the key information on all the risk factors and breast cancer with particular focus on the potential role of certain chemicals in the environment. It is written in a language that is accessible to non-scientists and is suitable for the general public and breast cancer suffers.
The briefing is available for downloading as a PDF document in several languages:
| | | |
| | | |
This briefing will also be available in Polish and Czech very soon.
This leaflet briefly describes the evidence that hormonally active chemicals may be implicated in breast cancer. Written for sufferers and a wide public audience, the leaflet highlights the risk factors for breast cancer, the views of several scientific groups concerning the role of chemicals, and what people can do to minimize exposure. It also briefly describes the policy actions needed in order to reduce exposures to hormonally active chemicals.
The leaflet is available for downloading as a PDF document in several languages:
| | | |
| | | |
| |
This leaflet will also be available in Polish very soon.
The Portfolio is a selection of peer-reviewed and published papers presenting the scientific case for chemical exposures playing a role in breast cancer. The portfolio includes two principal strands of compelling research. Firstly, large ongoing epidemiological studies and other epidemiological studies suggesting an association between certain chemical exposures and breast cancer that have not been contradicted by other studies. Secondly, papers illustrating demonstrable changes in mammary tissue due to low level in-utero exposures to certain chemicals in experimental animals. These papers will help take forward the discussion on the mechanism of action. The purpose of the portfolio is to provide a useful resource for clinicians, scientists, breast cancer charities, and other health professionals.
The portfolio has been compiled by Gwynne Lyons of CHEM Trust for HEAL and has been reviewed by several international experts in the field. If in your opinion, other studies should be included, please contact Gwynne Lyons at gwynne.lyons@chemtrust.org.uk.
The list of abstracts and full articles included in this portfolio: